谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

KRAS Mutational Status and Efficacy in KEYNOTE-189: Pembrolizumab (pembro) Plus Chemotherapy (chemo) Vs Placebo Plus Chemo As First-Line Therapy for Metastatic Non-Squamous NSCLC

S. Gadgeel,D. Rodriguez-Abreu,E. Felip,E. Esteban,G. Speranza,M. Reck,R. Hui,M. Boyer,E. B. Garon,H. Horinouchi,R. Cristescu,D. Aurora-Garg,J. Lunceford,J. Kobie,M. Ayers,B. Piperdi,M. C. Pietanza,M. C. Garassino

Annals of oncology（2019）

引用 49|浏览101
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要